BioAtrium ist ein gemeinschaftliches Joint Venture zwischen Lonza und Sanofi.
«Zweck der Gesellschaft ist die Konstruktion, Eigentum und der Betrieb einer biopharmazeutischen Säugetierzellkultur-Produktionsanlage und die Entwicklung, Herstellung und Lieferung von biopharmazeutischen Zellkultur-Produkten.
Company Details
- Employees
- 35
- Address
- Lonzastrasse, Bioatrium K02,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.bioatrium.com/
- Keywords
- Manager jobs.
- HQ
- Visp, Valais
Bioatrium Ag Questions
Bioatrium Ag's website is https://www.bioatrium.com/
Bioatrium Ag's LinkedIn profile is https://ch.linkedin.com/company/bioatrium-ag
Bioatrium Ag has
35 employees.
View email and phone details for 35
employees at Bioatrium Ag.
Bioatrium Ag's industry is
Pharmaceutical Manufacturing
Bioatrium Ag's top competitors are
Rentschler Biopharma,
Adryan,
Lonza,
Molecular Partners,
Advanced Accelerator Applications,
Roche,
Ten23 Health,
Dinaqor,
Evitria Ag,
Atlas Antibodies.
Bioatrium Ag's categories are Pharmaceutical Manufacturing
